Skip to content
healthcare.dev
Get a free key

Deferoxamine mesylate

NDC 68083-173, Deferoxamine mesylate, injection, powder, lyophilized, for solution, from Gland Pharma Limited.

Product NDC
68083-173
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207384
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFEROXAMINE MESYLATE2 g/1

Pharmacologic classes

Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
68083-173-01680830173014 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/598fba68-f46e-4b6e-894c-63c2940b2063

Use it

Look up 68083-173 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-173 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-173. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.